Tianjin Lisheng Pharmaceutical Co.,Ltd. (SHE:002393)
China
· Delayed Price · Currency is CNY 16.67
-0.14 (-0.83%)
Apr 30, 2026, 1:55 PM CST
SHE:002393 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Operating Revenue | 1,351 | 1,389 | 1,332 | 1,145 | 1,141 | 1,087 | Upgrade
|
| Other Revenue | 3.36 | 3.36 | 4.01 | 7.7 | 6.05 | 4.67 | Upgrade
|
| Revenue | 1,354 | 1,392 | 1,336 | 1,153 | 1,147 | 1,092 | Upgrade
|
| Revenue Growth (YoY) | 0.99% | 4.18% | 15.88% | 0.56% | 5.00% | -4.29% | Upgrade
|
| Cost of Revenue | 638.13 | 644.93 | 624.04 | 487.97 | 510.51 | 473.95 | Upgrade
|
| Gross Profit | 716.32 | 747.08 | 712.11 | 665.06 | 636.08 | 618 | Upgrade
|
| Selling, General & Admin | 485.5 | 520.47 | 500.39 | 424.61 | 448.45 | 466.29 | Upgrade
|
| Research & Development | 102.15 | 112.93 | 122.1 | 102.48 | 102.26 | 100.82 | Upgrade
|
| Other Operating Expenses | 20.17 | 20.62 | 20.19 | 19.64 | 24.1 | 22.33 | Upgrade
|
| Operating Expenses | 607.43 | 653.62 | 642.7 | 546.47 | 575.03 | 589.34 | Upgrade
|
| Operating Income | 108.89 | 93.46 | 69.41 | 118.6 | 61.05 | 28.66 | Upgrade
|
| Interest Expense | -2.25 | -2.25 | -2.66 | -0.75 | -0.88 | -0.32 | Upgrade
|
| Interest & Investment Income | 378.51 | 376.29 | 147.31 | 76.03 | 91.93 | 106.85 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.02 | -0.02 | 0.01 | 0.01 | 0.11 | -0.06 | Upgrade
|
| Other Non Operating Income (Expenses) | -23.25 | -0.16 | -0.7 | 2.23 | -2.16 | -0.18 | Upgrade
|
| EBT Excluding Unusual Items | 461.87 | 467.32 | 213.37 | 196.12 | 150.05 | 134.95 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | -4.99 | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | 2.45 | 2.11 | 2.9 | 0.62 | 0.28 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.3 | 0.25 | -0.1 | 238.7 | -34.82 | - | Upgrade
|
| Asset Writedown | -4.08 | -4.08 | -0.3 | -15.27 | -1.2 | -1.61 | Upgrade
|
| Other Unusual Items | -9.99 | -9.99 | 0.07 | 5.02 | 4.05 | 3.78 | Upgrade
|
| Pretax Income | 450.55 | 455.61 | 215.95 | 420.21 | 118.36 | 137.12 | Upgrade
|
| Income Tax Expense | 31.33 | 32.88 | 29.99 | 58.39 | 24.76 | 15.01 | Upgrade
|
| Earnings From Continuing Operations | 419.22 | 422.73 | 185.96 | 361.83 | 93.61 | 122.11 | Upgrade
|
| Minority Interest in Earnings | -6.33 | -6.44 | -1.43 | - | - | - | Upgrade
|
| Net Income | 412.89 | 416.28 | 184.53 | 361.83 | 93.61 | 122.11 | Upgrade
|
| Net Income to Common | 412.89 | 416.28 | 184.53 | 361.83 | 93.61 | 122.11 | Upgrade
|
| Net Income Growth | 128.56% | 125.59% | -49.00% | 286.54% | -23.34% | 1317.31% | Upgrade
|
| Shares Outstanding (Basic) | 307 | 308 | 308 | 310 | 308 | 306 | Upgrade
|
| Shares Outstanding (Diluted) | 307 | 308 | 308 | 310 | 308 | 306 | Upgrade
|
| Shares Change (YoY) | -0.70% | 0.26% | -0.83% | 0.59% | 0.70% | 5.91% | Upgrade
|
| EPS (Basic) | 1.34 | 1.35 | 0.60 | 1.17 | 0.30 | 0.40 | Upgrade
|
| EPS (Diluted) | 1.34 | 1.35 | 0.60 | 1.17 | 0.30 | 0.40 | Upgrade
|
| EPS Growth | 130.17% | 125.00% | -48.57% | 284.29% | -23.87% | 1238.26% | Upgrade
|
| Free Cash Flow | 214.7 | 210.04 | 34.51 | 138.29 | 290.47 | 108.1 | Upgrade
|
| Free Cash Flow Per Share | 0.70 | 0.68 | 0.11 | 0.45 | 0.94 | 0.35 | Upgrade
|
| Dividend Per Share | 0.750 | 0.750 | 0.292 | 0.357 | 0.179 | 0.179 | Upgrade
|
| Dividend Growth | 157.11% | 157.11% | -18.31% | 99.94% | - | 200.17% | Upgrade
|
| Gross Margin | 52.89% | 53.67% | 53.30% | 57.68% | 55.48% | 56.60% | Upgrade
|
| Operating Margin | 8.04% | 6.71% | 5.20% | 10.29% | 5.32% | 2.62% | Upgrade
|
| Profit Margin | 30.48% | 29.90% | 13.81% | 31.38% | 8.16% | 11.18% | Upgrade
|
| Free Cash Flow Margin | 15.85% | 15.09% | 2.58% | 11.99% | 25.33% | 9.90% | Upgrade
|
| EBITDA | 181.28 | 167.03 | 147.7 | 185.03 | 126.25 | 87.94 | Upgrade
|
| EBITDA Margin | 13.38% | 12.00% | 11.05% | 16.05% | 11.01% | 8.05% | Upgrade
|
| D&A For EBITDA | 72.39 | 73.57 | 78.29 | 66.43 | 65.2 | 59.28 | Upgrade
|
| EBIT | 108.89 | 93.46 | 69.41 | 118.6 | 61.05 | 28.66 | Upgrade
|
| EBIT Margin | 8.04% | 6.71% | 5.20% | 10.29% | 5.32% | 2.62% | Upgrade
|
| Effective Tax Rate | 6.95% | 7.22% | 13.89% | 13.89% | 20.92% | 10.95% | Upgrade
|
| Revenue as Reported | 1,392 | 1,392 | 1,336 | 1,153 | 1,147 | 1,092 | Upgrade
|
| Advertising Expenses | - | 247.48 | 266.99 | 253.43 | 264.36 | 283.37 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.